Information Journal Paper
APA:
Copy. (2019). Baicalein administered in the subacute phase ameliorates ischemiareperfusion-induced brain injury by reducing neuroinflammation and neuronal damage. BIOMEDICINE & PHARMACOTHERAPY, 117(-), 0-0. SID. https://sid.ir/paper/751653/en
Vancouver:
Copy. Baicalein administered in the subacute phase ameliorates ischemiareperfusion-induced brain injury by reducing neuroinflammation and neuronal damage. BIOMEDICINE & PHARMACOTHERAPY[Internet]. 2019;117(-):0-0. Available from: https://sid.ir/paper/751653/en
IEEE:
Copy, “Baicalein administered in the subacute phase ameliorates ischemiareperfusion-induced brain injury by reducing neuroinflammation and neuronal damage,” BIOMEDICINE & PHARMACOTHERAPY, vol. 117, no. -, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/751653/en